Company Filing History:
Years Active: 2025
Title: Peter Mellroth: Innovator in Streptococcal Vaccines
Introduction
Peter Mellroth is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of immunology, particularly in the development of vaccines. His innovative work focuses on creating effective immunogenic compositions to combat bacterial infections.
Latest Patents
Mellroth holds a patent for his work on streptococcal vaccines. The patent describes an immunogenic composition comprising bacterial membrane vesicles (MVs) that include a streptococcal MalX antigen and/or a streptococcal PrsA antigen. Notably, the MVs do not contain an immunogenic amount of a streptococcal PspA antigen. This composition has potential medical uses, especially for immunization against pneumococcal disease, and outlines methods for manufacturing the composition.
Career Highlights
Peter Mellroth is associated with Zalvac AB, where he continues to advance his research in vaccine development. His work is pivotal in addressing public health challenges related to bacterial diseases.
Collaborations
Mellroth collaborates with esteemed colleagues, including Birgitta Henriques Normark and Staffan Normark, who contribute to his research endeavors.
Conclusion
Peter Mellroth's innovative work in the field of streptococcal vaccines exemplifies his commitment to improving public health through scientific research. His contributions are vital in the ongoing fight against bacterial infections.